Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Tarrytown, New York
- Most recent report
- 10-Q, filed Jul 30, 2026
- Incorporated
- New York
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 872589
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 38
News 8 of 89
Prospectuses and Registrations 8 of 12
- S-3ASR Automatic shelf registration Oct 31, 2024
- S-3ASR Automatic shelf registration Nov 4, 2021
- 424B5 Prospectus supplement for an offering Aug 11, 2020
- FWP Free writing prospectus Aug 7, 2020
- 424B3 Prospectus supplement for an offering Aug 7, 2020
- S-8 Registration statement for an employee plan Jun 16, 2020
- 424B3 Prospectus supplement for an offering May 28, 2020
- 424B3 Prospectus supplement for an offering May 26, 2020
Proxies 8 of 31
- DEFA14A Extra proxy material Apr 24, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- PRE 14A Preliminary proxy statement Apr 7, 2025
- DEFA14A Extra proxy material Apr 25, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2024
- PX14A6G Shareholder's own proxy material May 18, 2023
Ownership 8 of 793
- 4 Insider reported a trade Aug 12, 2026
- 4 Insider reported a trade Aug 12, 2026
- 144 Notice of a proposed sale of restricted stock Aug 10, 2026
- 144 Notice of a proposed sale of restricted stock Aug 10, 2026
- 13F-HR Quarterly report of institutional holdings Aug 7, 2026
- 4 Insider reported a trade Jul 7, 2026
- 144 Notice of a proposed sale of restricted stock Jul 2, 2026
- 13F-HR Quarterly report of institutional holdings May 8, 2026
Other 8 of 37
- ARS Annual report sent to shareholders Apr 24, 2026
- ARS Annual report sent to shareholders Apr 29, 2025
- UPLOAD Comment letter from SEC staff Apr 17, 2025
- CORRESP Reply to SEC staff Apr 3, 2025
- UPLOAD Comment letter from SEC staff Mar 21, 2025
- UPLOAD Comment letter from SEC staff Sep 11, 2024
- CORRESP Reply to SEC staff Aug 1, 2024
- UPLOAD Comment letter from SEC staff Jul 22, 2024
Everything here comes from Regeneron Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.